Philip Charles Hoffman to Sirolimus
This is a "connection" page, showing publications Philip Charles Hoffman has written about Sirolimus.
Connection Strength
0.095
-
Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
Score: 0.095
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.